Nystrom & Associates Vantage Point

Type of Care

Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

Outpatient Partial hospitalization/day treatment

Facility Type

Outpatient mental health facility

Pharmacotherapies

Chlorpromazine Fluphenazine Haloperidol Loxapine Perphenazine Prochlorperazine Thiothixene Thioridazine Trifluoperazine Aripiprazole Asenapine Brexpiprazole Cariprazine Clozapine IIoperidone Lurasidone Olanzapine Olanzapine/Fluoxetine combination Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI

Treatment Approaches

Cognitive behavioral therapy Couples/family therapy Dialectical behavior therapy Group therapy Individual psychotherapy Telemedicine/telehealth therapy

Facility Operation (e.g., Private, Public)

Private for-profit organization

Payment/Insurance/Funding Accepted

County or local government funds Medicare Medicaid Federal military insurance (e.g., TRICARE) Private health insurance Cash or self-payment State-financed health insurance plan other than Medicaid State welfare or child and family services funds U.S. Department of VA funds

Special Programs/Groups Offered

Clients with co-occurring mental and substance use disorders

Assessment/Pre-treatment

Screening for tobacco use

Testing

Laboratory testing

Education and Counseling Services

Smoking/vaping/tobacco cessation counseling

Facility Smoking Policy

Smoking permitted in designated area

Age Groups Accepted

Children/Adolescents Young Adults Adults Seniors

Facility Vaping Policy

Vaping permitted in designated area

Ancillary Services

Court-ordered outpatient treatment Diet and exercise counseling Family psychoeducation Case management service Suicide prevention services